Huons to donate 6,000 glucose monitoring devices to local community

김주연 2024. 1. 16. 18:41
글자크기 설정 파란원을 좌우로 움직이시면 글자크기가 변경 됩니다.

이 글자크기로 변경됩니다.

(예시) 가장 빠른 뉴스가 있고 다양한 정보, 쌍방향 소통이 숨쉬는 다음뉴스를 만나보세요. 다음뉴스는 국내외 주요이슈와 실시간 속보, 문화생활 및 다양한 분야의 뉴스를 입체적으로 전달하고 있습니다.

Local biomanufacturing and health care company Huons will donate 6,000 glucose monitoring devices to a local community for diabetic patients.
Pictured is the Dexcom G6 continuous glucose monitoring (CGM) system, which is used by patients with type 1 diabetes to track blood sugar levels. The device is distributed domestically by local health care company Huons. [DEXCOM]

Local biomanufacturing and health care company Huons will donate 6,000 glucose monitoring devices to a local community for diabetic patients.

Huons said Tuesday it will donate its Dexcom G6 continuous glucose monitoring (CGM) devices to the Korean Society of Type 1 Diabetes, an organization that aims to promote healthy diabetes management and advocate for the consumer rights of people with diabetes. The CGM device enables patients to track their blood sugar levels.

Type 1 diabetes is a chronic condition in which the patient’s pancreas does not make insulin. The condition is difficult to cure and requires constant monitoring and management to avoid hypoglycemia, which is when blood sugar (glucose) levels fall below the standard range.

Patients with the condition are advised to make healthy food choices, eat consistent amounts throughout the day to control blood sugar levels and regularly exercise, especially as it can lower the chance of diabetes-related problems such as heart disease, kidney disease and nerve damage.

Ahead of the donation, Huons has also provided Dexcom G6 transmitters to patients with type 1 and type 2 diabetes in June last year.

“We decided to donate the Dexcom G6 CGM devices to aid patients suffering from diabetes. We will continuously strive to aid diabetes patients in need,” said Huons in a statement.

BY KIM JU-YEON [kim.juyeon2@joongang.co.kr]

Copyright © 코리아중앙데일리. 무단전재 및 재배포 금지.

이 기사에 대해 어떻게 생각하시나요?